|
2022
|
Invention
|
Quinuclidine-3-one derivatives. The invention relates to certain substituted quinuclidine-3-one c... |
|
2021
|
Invention
|
Combination treatment with a p53 reactivator and an inhibitor of cd47 mediated signaling. TPTP53. |
|
2020
|
Invention
|
Combination treatment with a p53 reactivator and an inhibitor of an antiapoptotic bcl-2 family pr... |
|
|
Invention
|
Combination treatment with a p53 reactivator and an inhibitor of dna methyltransferase post stem ... |
|
2019
|
Invention
|
Method of treatment and pharmaceutical dosage form.
The invention relates to a method of treatme... |
|
|
Invention
|
Method of treatment and pharmaceutical dosage form. TP53TP53 with a combination of APR-246 and az... |
|
|
Invention
|
Quinuclidine-3-one derivatives and their use in cancer treatment.
The invention relates to certa... |
|
|
Invention
|
Quinuclidine-3-one derivatives and their use in cancer treatment. The invention relates to certai... |
|
2011
|
Invention
|
Aqueous solution comprising 3-quinuclidinones for the treatment hyperproliferative, autoimmune an... |
|
|
Invention
|
Aqueous solution comprising 3 - quinuclidinones for the treatment hyperproliferative, autoimmune ... |
|
2005
|
Invention
|
Azabicyclooctan-3-one derivatives and use thereof. Compounds of Formula (1) process for preparing... |
|
|
Invention
|
Azabicyclooctan-3-one derivatives and use thereof.
Compounds of Formula (I) processes ... |
|
2004
|
Invention
|
1-azabicyclo [2,2,2] octan-3-one derivatives. The present invention provides novel compounds, cor... |
|
2003
|
Invention
|
1-azabicyclo[2.2.2]octan-3-one derivatives and maleimide derivatives and their use for treating c... |
|
|
Invention
|
Use of low molecular weight compounds for preparing a medicament useful in treating mutant p53 me... |
